Search details
1.
Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1.
Br J Cancer
; 123(11): 1665-1672, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32939056
2.
Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients.
Histopathology
; 76(7): 976-987, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-31994214
3.
Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.
J Pathol
; 247(2): 214-227, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30350370
4.
Fluorescent In Situ Hybridization in Surgical Pathology Practice.
Adv Anat Pathol
; 25(4): 223-237, 2018 Jul.
Article
in English
| MEDLINE | ID: mdl-29727321
5.
Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
J Pathol
; 243(4): 496-509, 2017 12.
Article
in English
| MEDLINE | ID: mdl-29086922
6.
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.
Mod Pathol
; 30(7): 952-963, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28338653
7.
Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target.
Histopathology
; 70(3): 402-411, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-27599111
8.
MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.
Breast Cancer Res
; 18(1): 125, 2016 12 08.
Article
in English
| MEDLINE | ID: mdl-27931239
9.
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.
Mod Pathol
; 29(10): 1155-64, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27363491
10.
BRAF(V600E) and NRAS(Q61L/Q61R) mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting.
Histopathology
; 69(4): 680-6, 2016 Oct.
Article
in English
| MEDLINE | ID: mdl-27151331
11.
Atypical Ewing sarcoma breakpoint region 1 fluorescence in-situ hybridization signal patterns in bone and soft tissue tumours: diagnostic experience with 135 cases.
Histopathology
; 69(6): 1000-1011, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27385661
12.
Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome.
Histopathology
; 69(1): 25-34, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-26588661
13.
Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features.
Breast Cancer Res
; 16(5): 423, 2014 Oct 21.
Article
in English
| MEDLINE | ID: mdl-25331261
14.
The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy.
Breast Cancer Res
; 15(2): 203, 2013 Mar 28.
Article
in English
| MEDLINE | ID: mdl-23547970
15.
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.
Proc Natl Acad Sci U S A
; 107(51): 22231-6, 2010 Dec 21.
Article
in English
| MEDLINE | ID: mdl-21127264
16.
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX.
Breast Cancer Res
; 14(6): R143, 2012 Nov 05.
Article
in English
| MEDLINE | ID: mdl-23127292
17.
Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers.
Breast Cancer Res
; 13(2): R47, 2011 Apr 26.
Article
in English
| MEDLINE | ID: mdl-21521526
18.
The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression.
Breast Cancer Res
; 13(1): R19, 2011 Feb 09.
Article
in English
| MEDLINE | ID: mdl-21306611
19.
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers.
Breast Cancer Res
; 13(1): R9, 2011 Jan 21.
Article
in English
| MEDLINE | ID: mdl-21255398
20.
SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3.
Am J Surg Pathol
; 45(8): 1108-1117, 2021 08 01.
Article
in English
| MEDLINE | ID: mdl-34232604